Related Experiment Videos

Cancer immunomodulation by carbohydrate ligands for the lymphocyte receptor NKR-P1

M Pospisil1, L Vannucci, O Horvath

  • 1Department of Immunology and Gnotobiology, Laboratory of Natural Cell Immunity, Institute of Microbiology, Academy of Sciences, Prague 14220, Czech Republic.

Insights

Natural killer (NK) cells and T cells utilize C-type lectin proteins. Ganglioside GM2 and heparin-related oligosaccharides (IS) enhanced NK cell activity and reduced colorectal cancer incidence in rats.

Area of Science:

  • Immunology
  • Carbohydrate Chemistry
  • Cancer Research

Background:

  • Natural killer (NK) and T cells express C-type lectin-like proteins.
  • The rat NKR-P1 (CD161) receptor binds to specific carbohydrate structures.

Purpose of the Study:

  • To investigate the therapeutic potential of ganglioside GM2 and heparin-related oligosaccharides (IS) in a rat model of colorectal cancer.
  • To assess the effect of GM2 and IS on cancer incidence when delivered via liposomes.

Main Methods:

  • Recombinant soluble rat NKR-P1 was used to identify its carbohydrate ligands.
  • In vitro studies assessed the effect of GM2 and IS on the cytotoxic activity of rat NK and T cells.
  • Liposomal formulations of GM2 and IS were administered to rats during induced colorectal carcinogenesis.

Main Results:

  • Rat NKR-P1 recognized GalNac and GlcNac moieties, with ganglioside GM2 and IS oligosaccharides identified as high-affinity ligands.
  • GM2 and IS significantly increased the sensitivity of target cells for killing by rat effector cells in vitro.
  • Liposomal GM2 and IS administration reduced colorectal cancer incidence in rats by 50%, comparable to 5-fluorouracil treatment (41.66% reduction).

Conclusions:

  • Ganglioside GM2 and heparin-related IS oligosaccharides can enhance NK cell-mediated cytotoxicity.
  • Liposomal delivery of GM2 and IS demonstrates significant therapeutic potential in reducing colorectal carcinogenesis in a rat model.

Related Concept Videos